CSF2 and COVID-19: Therefore, blocking GM-CSF or the GM-CSF receptor may be an effective treatment strategy to block the progression of acute respiratory failure in patients with COVID-19 by reducing the cytokine storm and the infiltration of inflammatory myeloid cells (102).